New York Cannabis Agency in Turmoil: Top Staff Quit After Gov. Hochul Calls It a 'Disaster'

New York's Cannabis Regulator Faces Exodus After Gov. Hochul's Criticism

The New York cannabis industry is facing a major shakeup as top staffers at the Office of Cannabis Management (OCM) are resigning following Gov. Kathy Hochul's scathing criticism of the agency's performance.

Key departures include:

• Nicole Rosa, Director of Health and Safety
• Danielle Holmes, Deputy Director for Licensing
• Patricia Piskorski Heer, First Deputy General Counsel
• Linda Baldwin, General Counsel

These departures mark a significant loss of institutional knowledge accumulated since the start of New York's medical marijuana program. The resignations come shortly after Hochul replaced the agency's head, Christopher Alexander, who was criticized for the agency's troubled rollout.

Hochul's Criticism and the Impact:

In May, Hochul released a report condemning the OCM for the program's troubled rollout, riddled with complaints and lawsuits. She stated that she would not reappoint Alexander, leading to his resignation two weeks later.

Concerns about Social Equity:

The governor's actions have raised concerns among cannabis insiders and lawmakers worried about the prioritization of social equity goals within the program. The Assemblywoman Michaelle Solages, chair of the Black, Puerto Rican, Hispanic and Asian American Caucus, expressed concern that the departures would negatively impact these goals.

Hochul's Response:

Hochul's spokesperson defended the agency's progress, highlighting the issuance of 730 new licenses and the opening of 150 stores. They attributed these achievements to the changes implemented by the governor.

Other Problems Plaguing the Program:

The OCM is not the only entity facing scrutiny. A fund designed to provide financing for cannabis entrepreneurs has been criticized as predatory, with high-interest loans based on inflated revenue projections.

The Dormitory Authority, a state agency, is also facing allegations of corruption concerning the fund, with a firm alleging that the former head sought illegal kickbacks from no-bid contracts.

The Future of New York's Cannabis Program:

The challenges facing the New York cannabis industry remain significant, with questions surrounding the program's effectiveness, fairness, and transparency. The recent departures and ongoing controversies raise concerns about the program's future and its ability to achieve its social equity goals.